Saying that it is yielding enough money, and it's aimed to cut costs, Google Inc, on Tuesday, announced that it is ceasing its two-year-old service to sell newspaper advertising, and thus gave a big blow to its own efforts to extend its ad program beyond web.

On its blog on Tuesday, the company stated that on Feb. 28 it will shut down its Print Ads program. Launched in November 2006, the program was fabricated to help newspapers make money by attracting Google advertisers to expand into print newspaper sales. About 800 U. S. newspapers were part of the program.

With the aim to buy a $225m stake in an Indian mobile phone company, Bahrain's national telecommunications operator has joined hands with a Dubai-based private equity business.

It was informed by Batelco (Bahrain Telecommunications Co) that it would take a 49 per cent stake together with Dubai's Millennium Private Equity in S Tel, an Indian mobile operator licensed to operate in six Indian states with a total population of about 230m people.

HCC, India's leading construction and infrastructure development Company, in joint venture with John Laing Investment Ltd and Sadbhav Engineering Ltd has bagged the prestigious order from National Highway Authority of India (NHAI) to construct the 96.5 km highway from Maharashtra-Madhya Pradesh Border to Dhule on NH-3 on BOT basis.

The joint venture, known as 'HCC-Laing-Sadbhav Consortium', has been awarded the project in the ratio of 37:36:27. The cost of the project is estimated at about Rs 1415 crore.

Country’s largest pharmaceutical company, Ranbaxy Laboratories Limited, announced that it has acquired manufacturing facilities that have the approval from the U.S. Food and Drug Administration (FDA).

Speaking on this, Malvinder Singh, CEO Ranbaxy Laboratories said, “We will transfer (production of) some products from India to America. Also, we are looking at making some acquisitions of manufacturing assets.”

He added that apart from US, his company is also keeping its options open to buy FDA-approved facilities from other countries.

Aurobindo Pharma Ltd has received US Food and Drug Administration (USFDA) approval to manufacture and market generic versions of epilepsy drug levetiracetam in variable strengths.

Aurobindo will manufacture and market the tablet in dosages of 250 milligram, 500 mg, 750 mg and 1,000 mg and an oral solution in 100 mg per millilitre dose.

Levetiracetam is an anticonvulsant drug used for the treatment of epilepsy. It is S- enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.

India’s largest technology, engineering, construction and manufacturing company Larsen & Toubro announced that it has signed up a memorandum of understanding (MoU) with US-based Westinghouse Electric Company (WEC), a group company of Toshiba Corporation.

The MoU has been signed in order to build 1,000 MW nuclear plants in India.

The MoU will successfully address the projected requirement in India for Pressurized Water Nuclear Reactors with Modular construction technology.